General Info
415 Capital is a venture capital firm specializing in breakthrough and life-saving medical innovation. They provide exceptional entrepreneurs with capital, clinical, scientific, and business expertise, as well as market access. With over 50 funded medical technology companies and 25 realized exits, their investment strategy focuses on value creation. Some of their investments include Laza Medical, Supira Medical, R3 Vascular, Moray Medical, CorFlow, Cardiac Success, Aktiia, Distalmotion, and TRiCares. Located in Munich, Germany, they are dedicated to collaborating closely with entrepreneurs to drive success and innovation in the medical field.
Location: Palo Alto, CA
Country: Germany
Industries:
Investment Regions:
Investment Stages: pre-seed, seed
Website: www.415x.com
angel-individual
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: very-active
AI Reasoning: Search results show a 415 Capital press release on March 26, 2025 about Supira Medical securing $120M Series E in which 415 Capital is listed. That investment activity is within 6 months from the target date, indicating recent activity. The invested startup named is Supira Medical.
Angel activity thresholds:
Low Activity – Only known angel investments more than 12 months ago.
Active – Known angel investments between the last 12 and 6 months.
Very Active – Known angel investments in the last 6 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of 415x
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI